Physician profile
Devan K Partridge
NPI 1427541051
$7,061.95
in general payments reported to CMS, 2019-2025
21 companies · $2,849 in 2025
The $2,849 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.40 · 2020: $89.92 · 2023: $1,492 · 2024: $2,568 · 2025: $2,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,190 · Travel and Lodging: $2,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,190.41 |
| Travel and Lodging | $2,719.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,402.25 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Saluda Medical Americas, INC. | $1,977.72 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic, INC. | $1,078.84 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Relievant Medsystems, INC. | $742.79 | 2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.76 | 2024-2025 | Relistor |
| Nevro Corp. | $83.11 | 2023-2024 | Senza |
| Biotronik Nro, INC. | $81.51 | 2025 | Prospera |
| Abbvie INC. | $81.46 | 2024-2025 | |
| Spinal Simplicity, LLC | $68.33 | 2025 | Ha Minuteman G3-R |
| Stryker Corporation | $66.01 | 2023 | Spinejack |
| Edwards Lifesciences Corporation | $62.40 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $59.47 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $57.22 | 2025 | |
| Globus Medical, INC. | $31.27 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $30.54 | 2023-2025 | Belbuca |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $29.34 | 2024 | Painteq |
| Averitas Pharma INC. | $20.97 | 2025 | Qutenza |
| Spr Therapeutics, INC | $19.35 | 2025 | Sprint Pns System |
| Pfizer INC. | $19.24 | 2025 | |
| Lundbeck LLC | $16.65 | 2024 | Vyepti |
| Vertos Medical, INC. | $10.72 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devan Partridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.